Top Markets
#1 Fake World Assets Fake World Assets +12.13%
#2 B3 (Base) B3 (Base) +7.21%
#3 OriginTrail OriginTrail +5.67%
#4 BasedHype BasedHype +5.04%
#5 Ontology Ontology +3.60%
#6 Dual Dual +3.59%
#7 Audiera Audiera +3.29%
#8 COTI COTI +3.23%
#9 Strategy PP Variable xStock Strategy PP Variable xStock +3.04%
#10 MVL MVL +2.41%
Coin of the day
Fake World Assets Fake World Assets
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Classificação em ações #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Preço da ação
$2.22
Última sincronização: 2026-08-21
Valor de mercado
$117.70M
Variação (1 dia)
2.69%
Variação (1 ano)
17.26%
País
SE
Negociar SynAct Pharma AB (SYNACT)

Categoria

Healthcare
Histórico de rendimento de dividendos para SynAct Pharma AB (SYNACT)
O rendimento de dividendos (TTM) da SynAct Pharma AB (símbolo da ação: SYNACT) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para SynAct Pharma AB (SYNACT) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
Empresa Rendimento de Dividendos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH